The opening price for East West Bancorp, Inc. (NASDAQ:EWBC) was $51.61 and the volume amounted to 608695 shares which compares with the average volume of 572980 shares. The company stock experienced a 2.66% move to arrive at $52.13.

East West Bancorp, Inc. (EWBC) Analyst Opinion

East West Bancorp, Inc. is currently rated as outperform by 14 stock analysts, with the company still having around 0.91% shares outstanding that can be sold short legally. The value of their shares went down by -1.16% last month. Over the course of a year, the stock has grown by 19.76%. Financial analysts are becoming more bullish than ever, with the 12 analysts who cover the activities of EWBC advising investors to buy. Experts on Wall Street have set a price target of $63.54 for the stock. The decision was arrived after looking at their 21.89% gain from current levels. At the moment, East West Bancorp, Inc. (EWBC) trading price is around -29.54% below its 52-week high.

East West Bancorp, Inc. Earnings Surprise

East West Bancorp, Inc. (EWBC) was successful in overcoming the expected $1.16 as the stock recorded an earnings of $1.18 a piece during their last financial report presentation. Revenue, meanwhile, had a distance of 4.15% from the previous quarter, with the company recording $363.2 million in revenue.

East West Bancorp, Inc. (NASDAQ:EWBC) Intraday View

The shares of East West Bancorp, Inc. (NASDAQ:EWBC) have struggled and recovered 30.16% ever since it recorded its 52 week low. During the course of 5 days, the stock price volatility has remained at 2.15%, increasing the time frame to a month, the volatility recorded was 2.62%. The price of their shares has been successful in staying above its 20 day-moving average, staying at a distance of 4.39% and while its 50-day moving average is around 0.28%. In a look at the previous five trading session EWBC stock has returned 1.5% and sank -6.5% when compared to its 200-day moving average that is $51.63. East West Bancorp, Inc. (EWBC) will look to overcome its -16.11% fall that it witnessed in the past year.

As the normal trading session ended, the stock of Sierra Oncology, Inc. (NASDAQ:SRRA), fetched in a $-0.05 retreat to $1.45. The session began with the stock price at $1.5, hitting a high of $1.509 before down again. For the week, analysts seem to be okay with their bullish with the consensus call staying at 0. Sierra Oncology, Inc. gets 2 buy analyst recommendations while 0 recommend a hold and 0 rated it as a sell. The shares of the company tumbled -60.81% from its high $3.7, with their overall market value now roughly $110.07 million.

Sierra Oncology, Inc. (SRRA) Consensus Price Target

The mean recommendation of SRRA on Reuter’s scale remained unchanged from 1.33 to 1.33 within 30 days. This figure implies that the majority of analysts rate it as a buy. The price target for Sierra Oncology, Inc. (NASDAQ:SRRA) is now around $6.67 a share, implying the stock has what it takes to grow by 360%. The recent trading session also indicated the stock needs to add 382.76% more meet analysts’ high consensus price target.

Sierra Oncology, Inc. (NASDAQ:SRRA) Intraday Trading

The current trading volume of the company was 302862 shares during the last session. That compares with the recent average volume of 302040 shares. By the end of the regular trading session, the price volatility over a 1-week span was 6.11 % while over a month it stood at 6.34%. The stock price of SRRA dropped to $1.4 during the day and at a certain time in 12 months it traded as low as $1.05. It has made a 38.32% recovery since its 52-week low point and has returned 9.85% year-to-date. [T3]